ChemoMetec ASOCSE:CHEMM +0.76%99 FCF Margin % is 22.13% as of Dec. 2025, which is 5% above its 10-year median of 21.06. GuruFocus rates OCSE:CHEMM with a GF Score™ of 99/100 and a GF Value™ of kr523.33 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 815 Medical Devices & Instruments companies, ChemoMetec AS ranks better than 95.95% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. ChemoMetec AS's Free Cash Flow for the
six
months ended in Dec. 2025 was kr55.1 Mil. ChemoMetec AS's Revenue for the
six
months ended in Dec. 2025 was kr249.0 Mil. Therefore, ChemoMetec AS's FCF Margin % for the quarter that ended in Dec. 2025 was 22.13%.
The historical rank and industry rank for ChemoMetec AS's FCF Margin % or its related term are showing as below:
OCSE:CHEMM'
s FCF Margin % Range Over the Past 10 Years
Min: -14.89 Med: 21.06 Max: 29.62
Current: 26.92
During the past 13 years, the highest FCF Margin % of ChemoMetec AS was 29.62%. The lowest was -14.89%. And the median was 21.06%.
OCSE:CHEMM's FCF Margin % is ranked better than 95.95% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.03
vs OCSE:CHEMM: 26.92
ChemoMetec AS FCF Margin % Related Terms
ChemoMetec AS FCF Margin % Historical Data
* Premium members only.
The historical data trend for ChemoMetec AS's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:CHEMM vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, ChemoMetec AS's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ChemoMetec AS FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's FCF Margin % distribution charts can be found below:
* The bar in red indicates where ChemoMetec AS's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoMetec AS (OCSE:CHEMM) has a FCF Margin % of 22.13% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ChemoMetec AS and its competitors. This is near median its historical median of 21.06. According to the industry distribution chart, ChemoMetec AS ranks #33 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 4%.
Is ChemoMetec AS's FCF Margin % too high?
ChemoMetec AS's current FCF Margin % of 22.13% is near median its 10-year median of 21.06. Based on the distribution chart, ChemoMetec AS ranks #33 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ChemoMetec AS ranks #33 out of 815 companies for FCF Margin %. This places ChemoMetec AS in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on ChemoMetec AS and its competitors. ChemoMetec AS's current FCF Margin % is 22.13%, which is near median its own 10-year median of 21.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (OCSE:CHEMM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr523.33, compared to a current price of kr369.20 — trading 29.5% below its estimated fair value. The current FCF Margin % is 22.13%, which is near median its 10-year median of 21.06. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For ChemoMetec AS (OCSE:CHEMM), the current FCF Margin % is 22.13% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ChemoMetec AS (OCSE:CHEMM) Overvalued in 2026?
Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued.
The current stock price of kr369.20 is trading 29.5% below its estimated GF Value™ of kr523.33.
GuruFocus considers ChemoMetec AS to be Modestly Undervalued.
Key valuation signals for OCSE:CHEMM:
FCF Margin %: 22.13% (near median its 10-year median of 21.06)
GF Value™: kr523.33 vs. price of kr369.20 (29.5% below fair value)
No single metric tells the full story. See the OCSE:CHEMM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score
Get the complete analysis for OCSE:CHEMM
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:CHEMM has been successfully added to your 
